NCT01569542

Brief Summary

By determining the correlation of a Crossed Leg Sign with significant pathology, a clinician would then be able to use this correlation to risk stratify his/her patients for significant pathology.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
400

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started May 2012

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 30, 2012

Completed
4 days until next milestone

First Posted

Study publicly available on registry

April 3, 2012

Completed
28 days until next milestone

Study Start

First participant enrolled

May 1, 2012

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2013

Completed
Last Updated

April 3, 2012

Status Verified

March 1, 2012

Enrollment Period

9 months

First QC Date

March 30, 2012

Last Update Submit

March 30, 2012

Conditions

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

This study should include all comers. To exclude a patient population would add a selection bias.

You may qualify if:

  • Any patient observed in the Emergency Department with sustained crossed legs.

You may not qualify if:

  • Any patient not observed to have sustained crossed legs and is not being used as a control.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Henry Ford Wyandotte Hospital

Wyandotte, Michigan, 48192, United States

Location

Study Officials

  • John D Uelk, DO

    Henry Ford Health System

    PRINCIPAL INVESTIGATOR

Central Study Contacts

John D Uelk, DO

CONTACT

Michael Ward, DO

CONTACT

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
INDIV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 30, 2012

First Posted

April 3, 2012

Study Start

May 1, 2012

Primary Completion

February 1, 2013

Study Completion

February 1, 2013

Last Updated

April 3, 2012

Record last verified: 2012-03

Locations